MAZE
Maze Therapeutics, Inc.
26.20$
-6.7%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | – | 100.0% | – | |
| – | – | 2.0% | – | |
| – | – | 100.0% | – | |
| – | – | 49.8% | – | |
| – | – | 15.8% | – | |
| – | – | 65.6% | – | |
| – | – | 34.4% | – | |
| – | – | 31.9% | – | |
| – | – | 0.7% | – | |
| – | – | 31.2% | – | |
| – | – | 33.9% | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.